Efficacy and safety of four dose regimes of a hypoallergenic recombinant birch pollen major allergen (rBet v 1-FV) in birch pollen allergic patients studied in an environmental exposure chamber

被引：0
|
作者：
Meyer, W. [1 ]
Narkus, A. [1 ]
Salapatek, A. [2 ]
Patel, D. [2 ]
Mussler, S. [1 ]
Haefner, D. [1 ]
机构：
[1] Allergopharma Joachim Ganzer KG, Dept Med, Reinbek, Germany
[2] Cetero Res, Med Affairs, Mississauga, ON, Canada
来源：
ALLERGY | 2012年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
187
引用
收藏
页码：89 / 89
页数：1
相关论文
共 50 条
  • [41] The recombinant major birch pollen allergen Bet v 1 induces mediator release in human intestinal mast cells
    Sellge, G
    Mierke, C
    Laffer, S
    Lorentz, A
    Manns, MP
    Valenta, R
    Bischoff, SC
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S304 - S304
  • [42] Human monoclonal IgG antibodies derived from a patient allergic to birch pollen as tools to study the in situ localization of the major birch pollen allergen, Bet v 1, by immunogold electron microscopy
    Grote, M
    Wiedemann, P
    Lebecque, S
    Valenta, R
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 101 (01) : 60 - 66
  • [43] Crystal structure of a hypoallergenic isoform of the major birch pollen allergen Bet v 1 and its likely biological function as a plant steroid carrier
    Markovic-Housley, Z
    Degano, M
    Lamba, D
    von Roepenack-Lahaye, E
    Clemens, S
    Susani, M
    Ferreira, F
    Scheiner, O
    Breiteneder, H
    JOURNAL OF MOLECULAR BIOLOGY, 2003, 325 (01) : 123 - 133
  • [44] Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients
    Nony, E.
    Le Mignon, M.
    Lemoine, P.
    Jain, K.
    Abiteboul, K.
    Arvidsson, M.
    Rak, S.
    Moingeon, P.
    ALLERGY, 2016, 71 : 61 - 61
  • [45] Mapping of IgG-binding epitopes on major birch pollen allergen Bet v 1 for identification of hypoallergenic peptides with potential therapeutic application
    Sosic, L.
    Paolucci, M.
    Melillo, D.
    Duda, A.
    Wackerle-Men, Y.
    Streuli, A.
    Eyer, K.
    Kundig, T.
    Johansen, P.
    SWISS MEDICAL WEEKLY, 2023, 153 : 15S - 15S
  • [46] Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients
    Nony, E.
    Bouley, J.
    Le Mignon, M.
    Lemoine, P.
    Jain, K.
    Horiot, S.
    Mascarell, L.
    Pallardy, M.
    Vincentelli, R.
    Leone, P.
    Roussel, A.
    Batard, T.
    Abiteboul, K.
    Robin, B.
    de Beaumont, O.
    Arvidsson, M.
    Rak, S.
    Moingeon, P.
    ALLERGY, 2015, 70 (07) : 795 - 804
  • [47] Mapping of IGG-binding epitopes in major birch pollen allergen Bet V 1 for identification of hypoallergenic peptides with potential therapeutic application
    Sosic, L.
    Melillo, D.
    Duda, A.
    Wackerle-Men, Y.
    Streuli, A.
    Eyer, K.
    Kundig, T.
    Johansen, P.
    ALLERGY, 2023, 78
  • [48] The recombinant major birch pollen allergen Bet v1 induces mediator release in human intestinal mast cells
    Sellge, G
    Laffer, S
    Lorentz, A
    Hegemann, B
    Manns, M
    Valenta, R
    Bischoff, SC
    GASTROENTEROLOGY, 2002, 122 (04) : A456 - A456
  • [49] Confirmation of immuno-reactivity of the recombinant major birch pollen allergen Bet v 1a by affinity-CIEF
    Dullnig, Verena
    Weiss, Richard
    Amon, Sabine
    Rizzi, Andreas
    Stutz, Hanno
    ELECTROPHORESIS, 2009, 30 (13) : 2337 - 2346
  • [50] PIPE cloning for rapid generation of recombinant antibodies of different classes against the major birch pollen allergen Bet v 1
    Koehler, V. K.
    Singer, J. F.
    Pranger, C. L.
    Ilieva, K. M.
    Karagiannis, S. N.
    Jensen-Jarolim, E.
    ALLERGY, 2018, 73 : 128 - 128
12345